{"docid":"VWS-WOO-08-663263","collapsed":true,"count":1,"unchecked":0,"snapshots_total":10,"versions":[{"archive_id":"6f138e93-428d-43e2-9f02-469ec6e29617","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2026-06-22 02:38:18","last_seen":"2026-06-22 02:38:18","from_file":"VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip","bron":"archieven_files\\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9","dupes":10,"date_to":"2026-06-22 02:38:18","date_from":"2025-02-18 12:18:03","unchecked":false}],"raw":[{"archive_id":"6f138e93-428d-43e2-9f02-469ec6e29617","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2026-06-22 02:38:18","last_seen":"2026-06-22 02:38:18","from_file":"VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip","bron":"archieven_files\\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"4762b6a4-dc85-4081-a2aa-5300e202fcb7","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2025-11-21 15:27:21","last_seen":"2026-06-22 01:38:45","from_file":"VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip","bron":"archieven_files\\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"c1ca2b19-e5d5-4cb0-b26a-6cd6fefabe16","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2025-11-21 15:15:27","last_seen":"2025-11-21 15:15:27","from_file":"VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip","bron":"archieven_files\\VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"folder_import_52331_e3698d317e58945093e0d968b78082d1","bestandsnaam":"VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf","created_date":"2025-09-08 18:29:09","last_seen":"2025-09-08 18:29:09","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/temp/VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"folder_import_37117_9d1f6361d0b1cad88fabeab400a9f86a","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2025-09-07 17:23:28","last_seen":"2025-09-07 17:23:28","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-663263.pdf","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip_2904","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2025-09-04 16:18:27","last_seen":"2025-11-21 13:47:41","from_file":"VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip","bron":"../../archieven_files/VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"423294","bestandsnaam":"VWS-WOO-08-663263.pdf","created_date":"2025-05-22 11:41:58","last_seen":"2025-05-22 11:41:58","from_file":"VWS-WOO-3324842-1025145-wjz.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\VWS-WOO-3324842-1025145-wjz.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"217883","bestandsnaam":"VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf","created_date":"2025-02-27 09:25:02","last_seen":"2025-02-27 09:25:02","from_file":"2023.057-VWS-WOO-3324842-1025145-wjz.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2023.057-VWS-WOO-3324842-1025145-wjz.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"178460","bestandsnaam":"VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf","created_date":"2025-02-18 12:36:08","last_seen":"2025-02-18 12:36:08","from_file":"Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"},{"archive_id":"54107","bestandsnaam":"VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf","created_date":"2025-02-18 12:18:03","last_seen":"2025-02-18 12:18:03","from_file":"Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip","snippet":"663263\nSurvey onthe Pharmaceutical Strategy Timely\npatient access toaffordable medicines\nFields marked with aremandatory\nIntroduction\nThe EUstrives tobeafrontrunner inensuring universal health coverag","digest":"41195857c6f9"}],"filename":"Centrient Pharmaceuticals_EU pharma strategy response_Final Draft.pdf","truncated":false,"elapsed_ms":7}